Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma.
Journal Information
Full Title: Neoplasia
Abbreviation: Neoplasia
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of Competing Interest All authors state that there are no potential conflicts of interest."
"Funding Sources The work presented in this study was supported, in part, by grant 5U54CA118948 and by institutional funds (Department of Pathology and School of Medicine of UAB) awarded to UM. We also acknowledge the grants (P30CA013148) funded for the Tissue Biorepository and imaging facilities, of the UAB OCCC. We also acknowledge the UAB Metabolism Core, which is supported by the UAB Diabetes Research Center (P30DK079626) and the UAB Center for Clinical and Translational Science (UL1TR003096)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025